Prof Susan Greenfield Chief Scientific Officer
Baroness Susan Greenfield CBE, co-founder of Neuro-Bio, conducts research on novel mechanisms of neurodegeneration at the University of Oxford. She has received 30 Honorary Degrees from British and foreign universities. Other awards include Michael Faraday Medal from the Royal Society (1998), Honorary Fellowship of the Royal College of Physicians (2000), L'Ordre National de la Légion d'Honneur (2003), American Academy of Achievement Golden Plate Award (2003), Honorary Fellowship of the Royal Society of Edinburgh (2007) and Australian Medical Research Society Medal (2010). To find out more go to www.susangreenfield.com.
Dr Gwënaël Pottiez Senior Biochemist
Dr Gwënaël Pottiez holds a Ph.D in Biochemistry, Master of Science and Bachelor of Science and is the biochemical expert in the team. His recent experience is working with Professor Greenfield at Oxford University. Dr Pottiez research includes the structure of the anatomical barrier separating the brain tissue from the blood stream which is a significant knowledge asset in neuroscience drug development. His post-doctoral project of research was based on the discovery of biomarkers in relation to viral infection, analyzing patient's blood. This provided him knowledge on clinical research and biomarker discovery related to human pathologies. His skills set include chemistry of proteins, pharmacology, mass spectrometry and software. Dr Pottiez has eight years project management of research projects and he enjoys the challenge to push scientific boundaries. Dr Pottiez is the main inventor, with Professor Susan Greenfield, in a Patent recently filed for biomarkers for Alzheimer's disease. Dr Pottiez has already been published fifteen times and has two book chapters to his name.
Dr Sara Garcia Ratés Senior Neurobiologist
Sara Garcia Ratés holds a PhD in Research, Development and Drug Control from the University of Barcelona (Spain) with the thesis "Interaction of the amphetamine derivates with the nicotinic receptors: Molecular and functional aspects". Her interest in the non-traditional properties of the nicotinic receptor attracted her to the position at the Department of Pharmacology of Oxford University as a Postdoctoral Researcher with Baroness Susan Greenfield, who explores novel approaches to neurodegeneration. This group published extensively on non-traditional actions of acetylcholinesterase (AchE) focusing their novel theory on the non-traditional actions of this 'AChE-peptide' and the interaction with an alternative or allosteric site of the α7-nAChR. Her particular project was concerned with the immediate therapeutic strategy to characterize the binding of the peptide to the specific receptor site in order to arrest further cell loss and then intercepting its further action that lead her to find a possible novel and effective candidate to cure Alzheimer's and other neurodegenerative diseases.
Mr Scott Badin Pharmacologist
Mr. Scott Badin holds a BSc (H) in Biological Sciences (Pharmacology) from The University of Edinburgh, and is now finishing his PhD in neuropharmacology at The University of Oxford. Mr. Badin is the pharmacologist expert of the group and focuses his research on the use of electrophysiology and voltage-sensitive dye imaging (VSDI) in order to monitor cortical activity at the meso-scale of brain organisation at physiologically-relevant spatio-temporal resolution (of millisecond and micrometers). Mr. Badin's first publication investigated the acute bioactivity of acetylcholine esterase-related peptides on in vitro cortical networks and validated the use of such on-line recording techniques as an adequate screening tool for probing the bioactivity and efficacy of drugs.
Mr Anthony Claydon Head of Finance
Anthony joined the team in August 2013 and provides a highly skilled and experienced Finance Director service to us. He is a Natural Sciences graduate of Durham University and a qualified Chartered Accountant since 1994. Anthony has been a full-time Finance Director or worked in a portfolio Finance Director capacity for over 14 years with more than 20 companies. These comprise owner managed businesses through to AIM quoted companies, have ranged from pre-revenue R&D businesses to multi-million pound services groups and covered a wide variety of industries. He focuses on businesses with fast growth potential and on developing strategy and successfully managing that expansion. Prior to that, he worked in corporate finance for 5 years with PwC and KPMG. Anthony is absolutely passionate about innovative, ambitious businesses in any sector and helping maximise and fulfil their potential. He describes his "first loves" to be technology and life sciences, where products or services can have a dramatic beneficial effect and create significant commercial return.
Mr John Burchill Head of LegalJohn Burchill is a senior commercial lawyer with extensive legal experience gained working for major UK and US companies as an in-house lawyer both in the UK and in Europe. He qualified as a Barrister in 1986. Strong on strategy and a relationship builder, he has advised businesses across a number of industry sectors including pharmaceuticals. He advises on general commercial contracts, M&A, employment law, management of disputes and litigation, franchising and a range of other legal matters. Increasingly John spends much of his time coordinating and providing strategic legal direction to businesses. He operates at Board level working with Chief Executives and Finance Directors acting in a trusted advisor role. John is based in London and works closely with Neuro-Bio's Chief Executive and Senior Management team.
Dr Nigel Toseland Pre-Clinical Scientist
Dr Nigel Toseland is a toxicological pathologist with over 34 years' experience in toxicology/pathology and risk evaluation in preclinical drug development with GlaxoSmithKline (GSK) until 2008. Nigel became a fellow of the Royal College of Pathologists in 1995. Nigel has worked on the preclinical development of several major GSK drugs including Paroxetine, Augmentin and Avandia. Nigel works at the university of Surrey as a course director (part-time) MSc Pharmaceutical Medicine, he is also a regular lecturer in toxicology/pathology at universities of Surrey, Cardiff, Brunel and the American College of Toxicology. He is the author or joint author of over 40 publications. Nigel is based in Chelmsford and works closely with Neuro-Bio's Chief Executive and Senior Management team.
Mrs Catherine Mulholland Head of HR
Catherine Mulholland is the part-time head of HR. She began her career in banking and administration, but moved across to generalist HR in 2000. Catherine recently completed a CIPD Award in Employment Law. She enjoys the energy of start-up businesses and has worked within a range of different industries including food manufacture, construction and now the Bio-Pharma sector. Catherine thrives on seeing new companies grow and develop; she lives in Oxfordshire with her two children aged 9 and 13.
Miss Emily Smith Office Manager
Emily Smith has had a wide range of experience in the service industry, from catering to leisure organisations: however for the last 18 months she has been personal assistant to Baroness Greenfield dealing with a range of sectors including academia, the media, finance and politics (House of Lords).